Agenus: Q4 Earnings Snapshot

robot
Abstract generation in progress

Agenus Inc. (AGEN) reported a Q4 loss of $10.6 million, or 37 cents per share, though earnings adjusted for non-recurring costs were 56 cents per share. The biotechnology company posted Q4 revenue of $34.2 million. For the full year, Agenus swung to a net income of $115,000 on revenue of $114.2 million, with shares trading at $3.29 at the close of Monday, up from $1.86 a year prior.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin